Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
Medtronic
Federal Trade Commission
Cipla
Fuji

Generated: August 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for CC-220

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for CC-220

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
CC-220   Try a Free Trial Methods of treating multiple myeloma with immunomodulatory compounds in combination with antibodies Celgene Corporation (Summit, NJ)   Try a Free Trial
CC-220   Try a Free Trial Formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione Celgene Corporation (Summit, NJ)   Try a Free Trial
CC-220   Try a Free Trial Methods for the treatment of diseases ameliorated by PDE4 inhibition using dosage titration of apremilast Celgene Corporation (Summit, NJ)   Try a Free Trial
CC-220   Try a Free Trial Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases CELGENE CORPORATION (Summit, NJ)   Try a Free Trial
CC-220   Try a Free Trial Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same Celgene Corporation (Summit, NJ)   Try a Free Trial
CC-220   Try a Free Trial 3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-- dione for the treatment of systemic lupus erythematosus Celgene Corporation (Summit, NJ)   Try a Free Trial
CC-220   Try a Free Trial Apremilast for the treatment of a liver disease or a liver function abnormality Celgene Corporation (Summit, NJ)   Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for CC-220

Drugname Country Document Number Estimated Expiration Related US Patent
CC-220 Australia 2015305449 2034-08-22   Try a Free Trial
CC-220 Brazil 112017003620 2034-08-22   Try a Free Trial
CC-220 Canada 2958867 2034-08-22   Try a Free Trial
CC-220 Chile 2017000416 2034-08-22   Try a Free Trial
CC-220 China 107073115 2034-08-22   Try a Free Trial
CC-220 Eurasian Patent Organization 201790439 2034-08-22   Try a Free Trial
CC-220 European Patent Office 3182996 2034-08-22   Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chubb
Federal Trade Commission
Julphar
Citi
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.